These studies are a catch-22. If they show that nicotine is delivered at a significant rate, the FDA gets to wave it over their heads and say, "See, we told you. It is the same as a prescription inhaler, a drug delivery system, and we need to regulate it." If the studies come out like this one, no significant delivery, they get to wave it and say, "See, these devices are being sold fraudulently and we need to regulate them!"![]()
interesting thought.